BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9563153)

  • 1. Brain metastasis as a sole recurrence of prostate cancer after total prostatectomy.
    Hayashi T; Igarashi K; Tanizawa A; Terada Y; Sekine H
    Urol Int; 1998; 60(2):121-3. PubMed ID: 9563153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An isolated pulmonary metastasis in prostate cancer.
    Hofland CA; Bagg MD
    Mil Med; 2000 Dec; 165(12):973-4. PubMed ID: 11149072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testicular metastasis as isolated recurrence after radical prostatectomy. A first case.
    Menchini-Fabris F; Giannarini G; Pomara G; De Maria M; Manassero F; Mogorovich A; Selli C
    Int J Impot Res; 2007; 19(1):108-9. PubMed ID: 16554855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain metastasis: an unusual complication from prostatic adenocarcinoma.
    Fervenza FC; Wolanskyj AP; Eklund HE; Richardson RL
    Mayo Clin Proc; 2000 Jan; 75(1):79-82. PubMed ID: 10630761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdural metastasis from adenocarcinoma of the prostate mimicking subdural hematoma: case report.
    Tomlin JM; Alleyne CH
    Surg Neurol; 2002 Nov; 58(5):329-31; discussion 331. PubMed ID: 12504300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of plasma intermedin levels with progression and metastasis in men after radical prostatectomy for localized prostatic cancer.
    Wang XL; Wang YY; He HD; Xie X; Yu ZJ; Pan YM
    Cancer Biomark; 2015; 15(6):799-805. PubMed ID: 26406405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late recurrence of a prostatic adenocarcinoma as a solitary splenic metastasis.
    Compérat E; Azzouzi AR; Chartier-Kastler E; Ménégaux F; Capron F; Richard F; Charlotte F
    Urol Int; 2007; 78(1):86-8. PubMed ID: 17192740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epididymal metastasis of a prostatic carcinoma.
    Anastasiadis AG; Ebert T; Gerharz CD; Ackermann R
    Urol Int; 1998; 60(2):124-5. PubMed ID: 9563154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging diagnosis of an intracranial metastasis of adenocarcinoma of the prostate: case report.
    Capito PR; Wang H; Brem H; Ahn HS; Bryan RN
    Md Med J; 1991 Feb; 40(2):113-5. PubMed ID: 1997794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables.
    Ferrari MK; McNeal JE; Malhotra SM; Brooks JD
    Urology; 2004 Oct; 64(4):749-53. PubMed ID: 15491714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
    Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
    Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated Testicular Metastasis of Prostate Cancer after Radical Prostatectomy: Case Report and Literature Review.
    Gibas A; Sieczkowski M; Biernat W; Matuszewski M
    Urol Int; 2015; 95(4):483-5. PubMed ID: 25659846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical remission after resection of prostate cancer lung metastasis.
    Chao DH; Higgins JP; Brooks JD
    Urology; 2004 Mar; 63(3):584-5. PubMed ID: 15028469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of positive resection margins in patients with pT2 prostate cancer. Implications for adjuvant treatment].
    Rosas-Nava JE; Herranz-Amo F; Paños-Fagundo EV; Lledó-García E; Verdú-Tartajo F; Hernández-Fernández C
    Actas Urol Esp; 2011 May; 35(5):272-6. PubMed ID: 21397985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical prostatectomy for clinical stage T3a disease.
    Freedland SJ; Partin AW; Humphreys EB; Mangold LA; Walsh PC
    Cancer; 2007 Apr; 109(7):1273-8. PubMed ID: 17315165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate specific antigen: not detectable despite tumor progression after radical prostatectomy.
    Goldrath DE; Messing EM
    J Urol; 1989 Oct; 142(4):1082-4. PubMed ID: 2477560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The surgical learning curve for prostate cancer control after radical prostatectomy.
    Vickers AJ; Bianco FJ; Serio AM; Eastham JA; Schrag D; Klein EA; Reuther AM; Kattan MW; Pontes JE; Scardino PT
    J Natl Cancer Inst; 2007 Aug; 99(15):1171-7. PubMed ID: 17652279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial treatment for solitary prostatic adenocarcinoma brain metastasis is curative.
    Sweets T; Bracken RB; Geisler EJ; Warnick R
    Urology; 2009 Mar; 73(3):681.e7-9. PubMed ID: 18502485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
    Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC
    J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient evaluation if prostate-specific antigen becomes elevated following radical prostatectomy or radiation therapy.
    Ferguson JK; Oesterling JE
    Urol Clin North Am; 1994 Nov; 21(4):677-85. PubMed ID: 7526514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.